Island Pharmaceuticals
Manufacturing · Australia · 1-10 Employees
View Company Info for Free
Overview
Headquarters
697 Burke Rd Ste 201, Camberwell, Victor...Phone Number
+61 390920475Revenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Island Pharmaceuticals
Island Pharmaceuticals is a clinical-stage drug repurposing company focused on developing antiviral therapeutics for infectious diseases. The company specializes in research and development within the pharmaceutical industry, with its primary asset being ISLA-101, a drug being repurposed for the prevention and treatment of dengue fever and other mosquito-borne diseases. Island Pharmaceuticals is advancing clinical trials for dengue-infected subjects and may be eligible for a Priority Review Voucher upon FDA approval, which could expedite future drug approvals or be sold in secondary markets. The company operates primarily in the business-to-business sector, providing innovative pharmaceutical solutions through scientific research and clinical development.Explore more
Island Pharmaceuticals Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Island Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Island Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Island Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Island Pharmaceuticals launches new products
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Island Pharmaceuticals has new funding data
Click to see if Island Pharmaceuticals had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Island Pharmaceuticals
Earning: See what the market has to say on Island Pharmaceuticals recently announced quarterly report
Check out if Island Pharmaceuticals is spiking on competitors!
Recommended Actions
Reach out to Masked Content who joined Island Pharmaceuticals as Masked Content
Find more new buyers
Compare Similar Companies to Island Pharmaceuticals
Compare insights from companies similar to Island Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Island Pharmaceuticals
<$5M
1-10
Private
<$5M
-
NM
Nick McCoyVice President, Clinical Product Development
Company Profile Activity
Activity Insights
Island Pharmaceuticals is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Island Pharmaceuticals is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Island Pharmaceuticals.
Island Pharmaceuticals financials insights
Gather financial insights about Island Pharmaceuticals, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2025
Other Financing Round
$2.7M
Stock/Share Issuance
$350K
Island Pharmaceuticals Tech Stack
A closer look at the technologies used by Island Pharmaceuticals
Island Pharmaceuticals News & Media
Island Pharmaceuticals Secures $350000 Funding Boost Through Options Exercise
Island Pharmaceuticals Ltd (ASX: ILA), an Australian antiviral drug development company focused on areas of unmet need for antiviral therapeutics to address infectious diseases, announced it has received $350,000 in new funding. This was secured through the exercise of 5,000,000 options at $0.07 per option by existing substantial shareholder, MWP Partners Limited. The company's leadIsland Pharmaceuticals Insider Ups Holding By 62% During Year
From what we can see, insiders were net buyers in Island Pharmaceuticals Limited's ( ASX:ILA ) during the past 12...One Island Pharmaceuticals Insider Raised Their Stake In The Previous Year
Looking at Island Pharmaceuticals Limited's ( ASX:ILA ) insider transactions over the last year, we can see that...Proactive news headlines including Spenda Ltd, Island Pharmaceuticals, Tempus Resources and Paradigm Biopharmaceuticals
Sydney, Dec. 28, 2022 (GLOBE NEWSWIRE) -- Proactive, provider of real-time news and video interviews on growth companies listed in Australia, has covered the following companies:
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Island Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Island Pharmaceuticals is a clinical-stage drug repurposing company focused on developing antiviral therapeutics for infectious diseases. The company specializes in research and development within the pharmaceutical industry, with its primary asset being ISLA-101, a drug being repurposed for the prevention and treatment of dengue fever and other mo... Read More
